Home | The Route to Recovery
In this issue
Mimotopes
Contents
News
VEGA Company Insight
VEGA Australia
Covid-19 executive briefing by GlobalData
Identifying a viable Covid-19 vaccine candidate and steps needed for its successful implementation
Impact of Covid-19 on patients with hepatocellular carcinoma
NSF
Novavax to receive $1.6B from Operation Warp Speed for the development of Covid-
FDA winners and losers in Covid-19 therapies
Pfeiffer Vacuum
Trials delayed due to Covid-19 begin to resume
ILC Dover
The pharma industry briefing
From rare diseases to Covid-19: charting the history of Genomics England
Covid-19: how will pharma cope with a looming recession?
Pandemic logistics: guaranteeing equitable access
Pandemic logistics: Resolving manufacturing and distribution challenges
Kugelmeiers
Q&A: how to find the right clinical trial participants with Innovative Trials
Recce Pharma: a new frontier in the fight against AMR
Autism pipeline: are better therapies in sight?
How a new crystallography technique may speed up drug development
Psychedelics: a game-changer in mental health?
Graph technology: the remedy for broken supply chains is connected data
Deals in brief powered by GlobalData
The key list powered by GlobalData
Global markets and indices powered by GlobalData
Macro-economic indicators (1 of 2) powered by GlobalData
Macro-economic indicators (2 of 2) powered by GlobalData
Events
Next issue
07/22/2020 00:00:00
Go to article:
Home | The Route to Recovery
Go to article:
In this issue
Go to article:
Mimotopes
Go to article:
Contents
Go to article:
News
Go to article:
VEGA Company Insight
Go to article:
VEGA Australia
Go to article:
Covid-19 executive briefing by GlobalData
Go to article:
Identifying a viable Covid-19 vaccine candidate and steps needed for its successful implementation
Go to article:
Impact of Covid-19 on patients with hepatocellular carcinoma
Go to article:
NSF
Go to article:
Novavax to receive $1.6B from Operation Warp Speed for the development of Covid-
Go to article:
FDA winners and losers in Covid-19 therapies
Go to article:
Pfeiffer Vacuum
Go to article:
Trials delayed due to Covid-19 begin to resume
Go to article:
ILC Dover
Go to article:
The pharma industry briefing
Go to article:
From rare diseases to Covid-19: charting the history of Genomics England
Go to article:
Covid-19: how will pharma cope with a looming recession?
Go to article:
Pandemic logistics: guaranteeing equitable access
Go to article:
Pandemic logistics: Resolving manufacturing and distribution challenges
Go to article:
Kugelmeiers
Go to article:
Q&A: how to find the right clinical trial participants with Innovative Trials
Go to article:
Recce Pharma: a new frontier in the fight against AMR
Go to article:
Autism pipeline: are better therapies in sight?
Go to article:
How a new crystallography technique may speed up drug development
Go to article:
Psychedelics: a game-changer in mental health?
Go to article:
Graph technology: the remedy for broken supply chains is connected data
Go to article:
Deals in brief powered by GlobalData
Go to article:
The key list powered by GlobalData
Go to article:
Global markets and indices powered by GlobalData
Go to article:
Macro-economic indicators (1 of 2) powered by GlobalData
Go to article:
Macro-economic indicators (2 of 2) powered by GlobalData
Go to article:
Events
Go to article:
Next issue